Viewing Study NCT06938503


Ignite Creation Date: 2025-12-24 @ 7:41 PM
Ignite Modification Date: 2026-01-01 @ 4:52 AM
Study NCT ID: NCT06938503
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-04-22
First Post: 2025-04-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: AG Plus Nimotuzumab Sequential Irreversible Electroporation Ablation for Locally Advanced Pancreatic Cancer
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module